Aortic Stents Grafts Market Size, Share, Growth, and Industry Analysis, By Type (Abdominal Aortic Stent Graft,Thoracic Aortic Stent Graft), By Application (Hospitals,Ambulatory Surgical Centers), Regional Insights and Forecast to 2035

Aortic Stents Grafts Market Overview

The global Aortic Stents Grafts Market is forecast to expand from USD 2665.23 million in 2026 to USD 2764.38 million in 2027, and is expected to reach USD 3703.9 million by 2035, growing at a CAGR of 3.72% over the forecast period.

The Aortic Stents Grafts Market has emerged as a vital segment of the global medical device industry, addressing complex aortic aneurysms with minimally invasive approaches. More than 65% of abdominal aortic aneurysm procedures globally now utilize endovascular stent grafts, compared to only 20% in the early 2000s.

The demand is reinforced by the fact that thoracic aortic aneurysms account for nearly 15% of aortic aneurysm cases worldwide, with over 60,000 new diagnoses annually. With an aging population, particularly in countries where 22% of citizens are above 60 years old, the adoption of aortic stents grafts continues to expand.

The USA accounts for nearly 38% of the global Aortic Stents Grafts Market, reflecting its strong adoption of minimally invasive cardiovascular procedures. Each year, over 200,000 cases of abdominal aortic aneurysms are diagnosed in the USA, with nearly 75% of patients undergoing some form of endovascular repair.

The widespread adoption is attributed to the fact that 92% of large hospital systems in the country are equipped with hybrid operating rooms designed for endovascular and open procedures. Data shows that nearly 55% of thoracic aortic aneurysm repairs in the USA are treated with thoracic endovascular aortic repair (TEVAR), a figure significantly higher than the global average of 40%.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: 72% of abdominal aneurysm repairs now use stent grafts, demonstrating a strong global shift toward minimally invasive aortic aneurysm repair procedures.
• Major Market Restraint: High device costs restrict adoption in low-income regions, where 60% of aneurysm patients remain untreated due to affordability and reimbursement limitations.
• Emerging Trends: 48% of new devices include fenestrated or branched grafts, while 35% integrate advanced imaging compatibility for improved deployment and procedural accuracy.
• Regional Leadership: North America leads with 38% market share, Europe follows at 32%, while Asia-Pacific rapidly expands, now accounting for 22% of total global adoption.
• Competitive Landscape: Medtronic and Cook Medical collectively hold 40% share, while Asian manufacturers contribute 18%, intensifying global competition in the aortic stents grafts industry.
• Market Segmentation: Abdominal stent grafts account for 58% of global procedures, thoracic stent grafts represent 42%, while hospitals dominate with 82% of overall usage worldwide.
• Recent Development: From 2023 to 2025, 30% of manufacturers launched AI-guided stent graft systems, improving deployment accuracy by 25% across multiple global clinical trials.

Aortic Stents Grafts Market Latest Trends

The Aortic Stents Grafts Market is witnessing major transformations driven by advanced imaging, material innovations, and patient-specific device designs. More than 52% of newly approved devices between 2023 and 2025 have incorporated customized fenestrated designs, supporting cases with irregular aortic anatomies.

Additionally, robotic-assisted deployment of stent grafts has been introduced in nearly 12% of major cardiovascular centers globally, reducing operative time by 20%. Another notable trend is the integration of AI and 3D imaging into EVAR procedures, which has improved deployment accuracy by 28%.

Aortic Stents Grafts Market Dynamics

DRIVER

"Growing Burden of Aortic Aneurysms"

Globally, nearly 3% of men above 65 years are diagnosed with abdominal aortic aneurysms, creating a consistent demand for repair procedures. More than 72% of these patients are recommended for endovascular treatment due to its reduced mortality benefits, where survival rates improve by 25% compared to open repair. Additionally, the shift toward minimally invasive approaches has led to a 40% decline in inpatient recovery time, enhancing hospital efficiency.

RESTRAINT

"Limited Access in Developing Regions"

While adoption is widespread in high-income countries, more than 55% of patients in developing regions remain untreated due to limited affordability and inadequate infrastructure. In sub-Saharan Africa, less than 10% of hospitals offer endovascular aneurysm repair, while in South Asia, only 30% of patients have access to trained specialists for EVAR.

OPPORTUNITY

"Expansion of Personalized and Branched Grafts"

The market is witnessing opportunities in personalized medicine, with 45% of new pipeline products focusing on branched or fenestrated grafts tailored for complex aortic structures. Hospitals using patient-specific 3D models report procedure success rates above 90%, compared to 72% for standard grafts. Asia-Pacific markets are showing strong demand, with nearly 20% of institutions piloting custom graft programs.

CHALLENGE

"High Device Costs and Training Requirements"

Aortic stent graft systems often cost 45% more than traditional surgical grafts, making widespread adoption difficult in low-resource settings. Beyond costs, nearly 50% of hospitals in middle-income countries lack adequately trained endovascular surgeons, leading to reliance on open repair methods. Even in developed regions, 28% of medical professionals report needing further training on complex fenestrated and branched graft systems.

Aortic Stents Grafts Market Segmentation

The Aortic Stents Grafts Market is segmented by type and application. Abdominal stent grafts account for 58% of procedures globally, while thoracic stent grafts contribute 42%. Hospitals remain the dominant end-users with 82% of market share, followed by ambulatory surgical centers at 18%.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Abdominal Aortic Stent Graft: This type accounts for the majority, with nearly 70% of EVAR procedures globally being abdominal-focused. More than 120,000 abdominal aneurysm repairs annually utilize stent grafts, with 60% of patients aged above 65 years. Hospitals report improved survival rates of 28% compared to open repair in abdominal cases.

The Abdominal Aortic Stent Graft segment is valued at USD 1510.45 million in 2025, representing 58.8% share, projected to reach USD 2062.14 million by 2034 at a CAGR of 3.55%.

Top 5 Major Dominant Countries in the Abdominal Aortic Stent Graft Segment

• United States accounts for USD 605.6 million in 2025 with 40.1% share, reaching USD 809.4 million by 2034 at 3.47% CAGR.
• Germany holds USD 181.2 million in 2025, capturing 12.0% share, projected to grow to USD 247.6 million by 2034 with 3.57% CAGR.
• Japan stands at USD 166.1 million in 2025 with 11.0% share, estimated to reach USD 229.9 million by 2034 at 3.71% CAGR.
• China records USD 136.0 million in 2025, securing 9.0% share, expected to achieve USD 192.7 million by 2034 while maintaining 3.92% CAGR.
• United Kingdom contributes USD 120.8 million in 2025, holding 8.0% share, anticipated to reach USD 165.1 million by 2034 at 3.61% CAGR.

Thoracic Aortic Stent Graft: Thoracic applications represent 42% of usage, with adoption particularly high in North America and Europe. Over 45,000 TEVAR procedures are performed annually worldwide, with a 22% higher success rate in preventing rupture compared to traditional surgery. Nearly 55% of TEVAR cases involve elderly patients above 70 years.

The Thoracic Aortic Stent Graft segment is valued at USD 1059.18 million in 2025, representing 41.2% share, projected to reach USD 1508.91 million by 2034 at a CAGR of 3.94%.

Top 5 Major Dominant Countries in the Thoracic Aortic Stent Graft Segment

• United States contributes USD 402.5 million in 2025, representing 38.0% share, projected to achieve USD 574.7 million by 2034 with 3.97% CAGR growth.
• France holds USD 148.3 million in 2025 with 14.0% share, expected to reach USD 211.5 million by 2034 at 4.03% CAGR.
• Japan posts USD 127.1 million in 2025, securing 12.0% share, projected to achieve USD 180.6 million by 2034 while maintaining 3.97% CAGR.
• China accounts for USD 106.0 million in 2025 with 10.0% share, forecasted to reach USD 152.7 million by 2034 at 4.02% CAGR.
• Canada records USD 74.1 million in 2025, representing 7.0% share, projected to hit USD 106.4 million by 2034 at 4.08% CAGR.

BY APPLICATION

Hospitals: Hospitals account for 82% of total procedures, driven by advanced surgical infrastructure. More than 90% of tertiary hospitals in developed regions perform EVAR procedures regularly. Hospitals also conduct 85% of clinical trials for new device launches.

Hospitals account for USD 2106.69 million in 2025, representing 82.0% share of the global market, projected to reach USD 2908.27 million by 2034 at a CAGR of 3.70%.

Top 5 Major Dominant Countries in the Hospitals Segment

• United States leads with USD 800.5 million in 2025, capturing 38.0% share, expected to reach USD 1113.1 million by 2034 with 3.71% CAGR.
• Germany secures USD 210.7 million in 2025, holding 10.0% share, projected to achieve USD 293.0 million by 2034 at a CAGR of 3.79%.
• Japan posts USD 189.6 million in 2025, capturing 9.0% share, estimated to hit USD 265.9 million by 2034 while maintaining 3.77% CAGR.
• China records USD 147.6 million in 2025, representing 7.0% share, forecasted to reach USD 208.3 million by 2034 at a CAGR of 3.87%.
• France contributes USD 126.4 million in 2025, capturing 6.0% share, expected to reach USD 177.9 million by 2034 with CAGR steady at 3.91%.

Ambulatory Surgical Centers: These facilities account for 18% of usage but are growing steadily due to shorter recovery stays. Nearly 40% of younger patients with lower-risk aneurysms prefer ambulatory centers, where average procedure times are reduced by 20% compared to hospitals.

Ambulatory Surgical Centers represent USD 462.94 million in 2025, accounting for 18.0% share, projected to reach USD 662.78 million by 2034 at a CAGR of 4.01%.

Top 5 Major Dominant Countries in the Ambulatory Surgical Centers Segment

• United States contributes USD 207.7 million in 2025 with 44.8% share, forecasted to reach USD 297.8 million by 2034 at 4.01% CAGR.
• United Kingdom holds USD 60.2 million in 2025, securing 13.0% share, expected to grow to USD 86.2 million by 2034 with 4.09% CAGR.
• Canada posts USD 50.9 million in 2025, accounting for 11.0% share, projected to hit USD 72.7 million by 2034 with CAGR of 4.10%.
• Australia values USD 41.7 million in 2025, holding 9.0% share, anticipated to reach USD 59.9 million by 2034 at 4.13% CAGR growth.
• Japan secures USD 36.9 million in 2025, capturing 8.0% share, estimated to reach USD 53.2 million by 2034 while sustaining 4.12% CAGR.

Aortic Stents Grafts Market Regional Outlook

North America leads with 38% share, followed by Europe at 32%, while Asia-Pacific grows fastest at 22%. Middle East & Africa contributes 8% with expanding adoption. Combined, these regions illustrate how demographics, healthcare infrastructure, and technology drive stent graft demand worldwide.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

NORTH AMERICA

North America holds 38% share of the Aortic Stents Grafts Market, making it the global leader. More than 70% of aneurysm repairs in the USA and Canada are endovascular. Around 92% of hospitals are equipped with hybrid operating rooms. With over 1,000 active clinical trials and strong manufacturer presence, the region dominates adoption in abdominal and thoracic stent graft applications, ensuring its continued leadership in advanced cardiovascular treatments.

North America holds USD 975.4 million in 2025, representing 38.0% share, and is projected to reach USD 1365.0 million by 2034 with CAGR of 3.80%.

North America – Major Dominant Countries in the Aortic Stents Grafts Market

• United States leads at USD 813.3 million in 2025, 83.4% share, projected USD 1135.4 million by 2034, maintaining consistent CAGR of 3.78%.
• Canada holds USD 97.5 million in 2025, capturing 10.0% share, estimated USD 137.4 million by 2034, with CAGR growth stable at 3.84%.
• Mexico stands at USD 39.0 million in 2025, 4.0% share, projected USD 56.2 million by 2034, sustaining strong CAGR performance of 4.13%.
• Brazil contributes USD 19.5 million in 2025, holding 2.0% share, expected USD 27.9 million by 2034, with CAGR expansion steady at 4.06%.
• Chile secures USD 6.2 million in 2025, 0.6% share, projected USD 8.9 million by 2034, sustaining consistent CAGR momentum of 4.02%.

EUROPE

Europe represents 32% of the global Aortic Stents Grafts Market, with Germany, France, and the UK contributing nearly 60% of regional demand. More than 75% of tertiary hospitals across Europe perform both EVAR and TEVAR procedures. Adoption of fenestrated and branched stents has reached 28% of total implants. Favorable regulations, high patient awareness, and rapid adoption of minimally invasive interventions position Europe as a strong market player in advanced endovascular treatments.

Europe accounts for USD 822.3 million in 2025, representing 32.0% share, projected to reach USD 1145.2 million by 2034, reflecting a steady CAGR of 3.81%.

Europe – Major Dominant Countries in the Aortic Stents Grafts Market

• Germany dominates at USD 197.3 million in 2025, 24.0% share, projected USD 273.0 million by 2034, supported by CAGR stability of 3.72%.
• France records USD 164.5 million in 2025, 20.0% share, estimated USD 228.2 million by 2034, sustaining CAGR momentum consistent at 3.77%.
• United Kingdom posts USD 131.6 million in 2025, 16.0% share, projected USD 183.3 million by 2034, sustaining CAGR levels steadily at 3.82%.
• Italy secures USD 115.1 million in 2025, 14.0% share, expected USD 160.2 million by 2034, maintaining CAGR growth consistently at 3.87%.
• Spain holds USD 98.6 million in 2025, 12.0% share, projected USD 137.9 million by 2034, sustaining CAGR development steadily at 3.91%.

ASIA-PACIFIC

Asia-Pacific holds 22% share of the Aortic Stents Grafts Market, with Japan, China, and India leading. Japan alone contributes 40% of regional procedures, while China has increased stent graft adoption by 25% in five years. Over 45% of advanced hospitals in the region are now EVAR-capable. Rising aneurysm prevalence among elderly populations ensures rapid demand growth, making Asia-Pacific the fastest-expanding market for aortic stent graft procedures and innovative device adoption globally.

Asia-Pacific is valued at USD 565.3 million in 2025, representing 22.0% share, projected to reach USD 784.6 million by 2034, showing a CAGR of 3.77%.

Asia-Pacific – Major Dominant Countries in the Aortic Stents Grafts Market

• Japan leads at USD 197.9 million in 2025, 35.0% share, projected USD 274.4 million by 2034, sustaining CAGR performance consistently at 3.79%.
• China posts USD 169.6 million in 2025, 30.0% share, expected USD 235.4 million by 2034, sustaining CAGR momentum reliably at 3.75%.
• India secures USD 84.8 million in 2025, 15.0% share, projected USD 118.4 million by 2034, maintaining CAGR expansion steadily at 3.81%.
• South Korea values USD 62.2 million in 2025, 11.0% share, estimated USD 87.6 million by 2034, sustaining CAGR improvement steadily at 3.85%.
• Australia records USD 50.8 million in 2025, 9.0% share, projected USD 68.8 million by 2034, sustaining CAGR trajectory consistently at 3.82%.

MIDDLE EAST & AFRICA

Middle East & Africa accounts for 8% of the global Aortic Stents Grafts Market, with GCC countries and South Africa driving demand. Less than 20% of African hospitals currently provide EVAR, though GCC adoption has grown by 15% since 2023. Around 60% of demand is concentrated in private healthcare systems. Improvements in infrastructure, expanded specialist training, and better access to advanced devices are gradually increasing adoption across this developing regional market.

Middle East & Africa holds USD 206.0 million in 2025, representing 8.0% share, projected to reach USD 276.2 million by 2034 with a steady CAGR of 3.73%.

Middle East and Africa – Major Dominant Countries in the Aortic Stents Grafts Market

• Saudi Arabia leads with USD 61.8 million in 2025, 30.0% share, projected USD 83.0 million by 2034, sustaining CAGR momentum reliably at 3.74%.
• South Africa posts USD 51.5 million in 2025, 25.0% share, estimated USD 69.0 million by 2034, maintaining CAGR progression consistently at 3.75%.
• United Arab Emirates secures USD 41.2 million in 2025, 20.0% share, projected USD 55.1 million by 2034, sustaining CAGR development reliably at 3.71%.
• Egypt values USD 30.9 million in 2025, 15.0% share, estimated USD 41.3 million by 2034, sustaining CAGR expansion steadily at 3.76%.
• Nigeria accounts for USD 20.6 million in 2025, 10.0% share, projected USD 27.8 million by 2034, sustaining CAGR growth consistently at 3.79%.

List of Top Aortic Stents Grafts Companies

• Cook Medical
• Terumo Corporation
• L. Gore & Associates
• Cardinal Health
• ENDOLOGIX
• R. Bard
• Medtronic
• MicroPort Scientific
• Bolton Medical
• Lombard Medical
• JOTEC

Top Two Companies with Highest Market Share:

• Medtronic: Holds 22% market share, with strong dominance in both abdominal and thoracic grafts across North America and Europe. Medtronic’s stent graft systems are used in over 70 countries, supported by clinical trial data from 15,000 patients worldwide.
• Cook Medical: Holds 18% share, with over 90,000 implantations annually. Its fenestrated graft portfolio accounts for 35% of its product usage, making it a leader in complex aneurysm treatment.

Investment Analysis and Opportunities

The Aortic Stents Grafts Market is attracting significant investments, with nearly 40% of manufacturers allocating more than 10% of annual budgets toward R&D between 2023 and 2025. In the Asia-Pacific region, investment inflows for advanced hybrid operating rooms have increased by 28%, expanding opportunities for stent graft procedures. Private equity firms have invested in more than 15 stent graft-focused companies since 2023, with nearly 30% of these targeting customized and fenestrated systems.

Hospitals report a 25% higher patient inflow for EVAR compared to open repairs, incentivizing investments into related imaging technologies and robotic-assisted interventions. Opportunities are significant in emerging economies, where adoption is below 30% but demand is rising due to growing cardiovascular disease prevalence, which affects nearly 35% of the adult population.

New Product Development

Innovation is central to the Aortic Stents Grafts Market, with 52% of product launches since 2023 focusing on fenestrated and branched designs for complex anatomies. Manufacturers are integrating nitinol with higher flexibility, offering 20% more resistance to kinking and migration. Robotic-assisted graft delivery systems, introduced in 2024, are now being used in nearly 15% of advanced centers, reducing procedure times by 18%.

AI-supported navigation tools in new devices improved placement precision by 25%, reducing complications significantly. Additionally, 3D-printed patient-specific grafts are gaining traction, with 12% of top hospitals piloting such technologies in 2025. Sustainability is also becoming a focus, with 22% of manufacturers incorporating recyclable packaging for medical shipments.

Five Recent Developments

• In 2023, Medtronic launched a branched thoracic stent graft system, adopted in 18% of TEVAR procedures in Europe within its first year.
• Cook Medical introduced a fenestrated abdominal stent graft in 2024, which increased procedural success rates by 30% in complex aneurysm cases.
• L. Gore & Associates announced AI-compatible graft deployment systems in 2024, improving accuracy by 22% across clinical trials.
• Terumo Corporation expanded its Asia-Pacific portfolio in 2025, securing 12% of the Japanese TEVAR market through new product introductions.
• MicroPort Scientific unveiled a low-profile graft delivery system in 2025, which reduced insertion-related complications by 17% in pilot studies.

Report Coverage of Aortic Stents Grafts Market

The Aortic Stents Grafts Market Report covers comprehensive analysis across product types, applications, and regional performance. The report highlights abdominal grafts contributing 58% of global procedures and thoracic grafts representing 42%. Hospitals account for 82% of overall demand, while ambulatory centers represent 18%.

Regionally, North America leads with 38% share, Europe follows with 32%, Asia-Pacific contributes 22%, and MEA accounts for 8%. Competitive analysis includes profiles of 11 leading companies, with Medtronic and Cook Medical dominating 40% combined share. The report also examines trends such as AI-guided systems, 3D printing, and robotic-assisted deployments. Between 2023 and 2025, over 30% of product launches were focused on customized graft solutions, underscoring the growing importance of personalization.

Aortic Stents Grafts Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 2665.23 Million in 2026
Market Size Value By	USD 3703.9 Million by 2035
Growth Rate	CAGR of 3.72% from 2026-2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Abdominal Aortic Stent Graft Thoracic Aortic Stent Graft By Application : Hospitals Ambulatory Surgical Centers
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample